Globus Medical Stock Buy Hold or Sell Recommendation
| GMED Stock | USD 85.29 0.76 0.90% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Globus Medical is 'Strong Buy'. Macroaxis provides Globus Medical buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding GMED positions.
Check out Globus Medical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide. Note, we conduct extensive research on individual companies such as Globus and provide practical buy, sell, or hold advice based on investors' constraints. Globus Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
Globus |
Execute Globus Medical Buy or Sell Advice
The Globus recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Globus Medical. Macroaxis does not own or have any residual interests in Globus Medical or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Globus Medical's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Buy
Market Performance | Good | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very Low | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Globus Medical Trading Alerts and Improvement Suggestions
| Over 82.0% of the company shares are owned by institutional investors | |
| Latest headline from zacks.com: STXS Stock Up Following the NMPA Clearance of Its Genesis RMN System |
Globus Medical Returns Distribution Density
The distribution of Globus Medical's historical returns is an attempt to chart the uncertainty of Globus Medical's future price movements. The chart of the probability distribution of Globus Medical daily returns describes the distribution of returns around its average expected value. We use Globus Medical price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Globus Medical returns is essential to provide solid investment advice for Globus Medical.
| Mean Return | 0.26 | Value At Risk | -1.59 | Potential Upside | 1.82 | Standard Deviation | 1.60 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Globus Medical historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Globus Stock Institutional Investors
| Shares | Geode Capital Management, Llc | 2024-09-30 | 1.9 M | Norges Bank | 2024-06-30 | 1.8 M | Champlain Investment Partners, Llc | 2024-09-30 | 1.8 M | Gw&k Investment Management, Llc | 2024-09-30 | 1.8 M | Geneva Capital Management | 2024-09-30 | 1.6 M | Citadel Advisors Llc | 2024-09-30 | 1.6 M | William Blair Investment Management, Llc | 2024-09-30 | 1.6 M | Axa Sa | 2024-06-30 | 1.5 M | Van Berkom And Associates Inc | 2024-09-30 | 1.5 M | Vanguard Group Inc | 2024-09-30 | 10.6 M | Blackrock Inc | 2024-06-30 | 10.3 M |
Globus Medical Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (50.0M) | (50.1M) | (12.0M) | (61.7M) | (70.3M) | (66.8M) | |
| Change In Cash | 56.0M | 43.7M | (46.3M) | (42.6M) | 316.8M | 332.7M | |
| Free Cash Flow | 101.2M | 135.1M | 219.4M | 104.4M | 165.2M | 106.5M | |
| Depreciation | 52.7M | 62.9M | 69.9M | 68.3M | 144.7M | 152.0M | |
| Other Non Cash Items | 7.1M | 48.5M | 61.5M | 14.7M | 97.5M | 102.4M | |
| Capital Expenditures | 70.8M | 63.7M | 56.9M | 74.0M | 78.3M | 49.9M | |
| Net Income | 155.2M | 102.3M | 149.2M | 190.2M | 122.9M | 117.5M | |
| End Period Cash Flow | 195.7M | 239.4M | 193.1M | 150.5M | 467.3M | 490.7M | |
| Change To Netincome | 37.5M | 71.3M | 71.9M | 22.6M | 26.0M | 34.2M | |
| Investments | (45.7M) | (20.2M) | (284.6M) | (4.9M) | (78.1M) | (82.0M) |
Globus Medical Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Globus Medical or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Globus Medical's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Globus stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.11 | |
β | Beta against Dow Jones | 1.15 | |
σ | Overall volatility | 1.63 | |
Ir | Information ratio | 0.08 |
Globus Medical Volatility Alert
Globus Medical has relatively low volatility with skewness of 3.0 and kurtosis of 16.28. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Globus Medical's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Globus Medical's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Globus Medical Fundamentals Vs Peers
Comparing Globus Medical's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Globus Medical's direct or indirect competition across all of the common fundamentals between Globus Medical and the related equities. This way, we can detect undervalued stocks with similar characteristics as Globus Medical or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Globus Medical's fundamental indicators could also be used in its relative valuation, which is a method of valuing Globus Medical by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Globus Medical to competition |
| Fundamentals | Globus Medical | Peer Average |
| Return On Equity | 0.0222 | -0.31 |
| Return On Asset | 0.0473 | -0.14 |
| Profit Margin | 0.04 % | (1.27) % |
| Operating Margin | 0.18 % | (5.51) % |
| Current Valuation | 11.35 B | 16.62 B |
| Shares Outstanding | 113.74 M | 571.82 M |
| Shares Owned By Insiders | 0.63 % | 10.09 % |
| Shares Owned By Institutions | 82.07 % | 39.21 % |
| Number Of Shares Shorted | 2.79 M | 4.71 M |
| Price To Earning | 73.16 X | 28.72 X |
| Price To Book | 2.83 X | 9.51 X |
| Price To Sales | 4.64 X | 11.42 X |
| Revenue | 1.57 B | 9.43 B |
| Gross Profit | 759.12 M | 27.38 B |
| EBITDA | 310.13 M | 3.9 B |
| Net Income | 122.87 M | 570.98 M |
| Cash And Equivalents | 408.01 M | 2.7 B |
| Cash Per Share | 4.10 X | 5.01 X |
| Total Debt | 520.4 M | 5.32 B |
| Debt To Equity | 0 % | 48.70 % |
| Current Ratio | 6.10 X | 2.16 X |
| Book Value Per Share | 29.94 X | 1.93 K |
| Cash Flow From Operations | 243.5 M | 971.22 M |
| Short Ratio | 2.59 X | 4.00 X |
| Earnings Per Share | 0.62 X | 3.12 X |
| Price To Earnings To Growth | 2.27 X | 4.89 X |
| Target Price | 90.54 | |
| Number Of Employees | 5 K | 18.84 K |
| Beta | 1.17 | -0.15 |
| Market Capitalization | 11.51 B | 19.03 B |
| Total Asset | 5.09 B | 29.47 B |
| Retained Earnings | 1.14 B | 9.33 B |
| Working Capital | 1.52 B | 1.48 B |
Note: Acquisition by Kelly Huller of 40000 shares of Globus Medical at 53.75 subject to Rule 16b-3 [view details]
Globus Medical Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Globus . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Globus Medical Buy or Sell Advice
When is the right time to buy or sell Globus Medical? Buying financial instruments such as Globus Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Globus Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Rubber and Plastic Products Thematic Idea Now
Rubber and Plastic Products
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Rubber and Plastic Products theme has 27 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Rubber and Plastic Products Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Globus Medical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Globus Medical. If investors know Globus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Globus Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 42.231 | Earnings Share 0.62 | Revenue Per Share 18.217 | Quarterly Revenue Growth 0.631 | Return On Assets 0.0473 |
The market value of Globus Medical is measured differently than its book value, which is the value of Globus that is recorded on the company's balance sheet. Investors also form their own opinion of Globus Medical's value that differs from its market value or its book value, called intrinsic value, which is Globus Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Globus Medical's market value can be influenced by many factors that don't directly affect Globus Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Globus Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Globus Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Globus Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.